Literature DB >> 433964

Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD).

J W Wynne, A J Block, J Hemenway, L A Hunt, M R Flick.   

Abstract

Seven patients with chronic obstructive lung disease (COLD) were monitored during their overnight sleep to determine the occurrence of disordered breathing and oxygen desaturation. Nasal and oral airflows were sensed by thermistor probes, chest wall movement by impedance pneumography and arterial oxygen saturation by ear oximetry. These variables were correlated with electroencephalographic and electrooculographic tracings. The subjects had a mean base line oxygen saturation of 89.2 per cent and slept an average of 218 minutes. Six of these seven subjects had one to 30 episodes of oxygen desaturation (decrease more than 4 per cent), 4 seconds to 30 minutes in duration, with declines in saturation as great as 36 per cent. In two subjects, saturation dropped to less than 50 per cent. Breathing was disordered in five of the seven subjects and included apnea and hypopnea. Subjects experienced from nine to 37 episodes of disordered breathing. Disordered breathing caused 42 per cent of the episodes of desaturation, all of which were less than 1 minute in duration. The mean maximum decline in saturation was 7.6 per cent. All episodes of desaturation lasting longer than 5 minutes occurred in rapid eye movement (REM) sleep and were not caused by disordered breathing. The mean maximal decrease in saturation was 22 per cent. This study reveals that disordered breathing is common in subjects with COLD and often causes desaturation but that it cannot explain all episodes of sleep desaturation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433964     DOI: 10.1016/0002-9343(79)91166-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

1.  British Thoracic Society summer meeting. 11-13 July 1990, Birmingham. Abstracts.

Authors: 
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

2.  High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

Authors:  Xavier Soler; Eduardo Gaio; Frank L Powell; Joe W Ramsdell; Jose S Loredo; Atul Malhotra; Andrew L Ries
Journal:  Ann Am Thorac Soc       Date:  2015-08

3.  Domiciliary ventilation in chronic obstructive pulmonary disease: where are we?

Authors:  J A Wedzicha; D J Meecham Jones
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

4.  Do asthmatics suffer bronchoconstriction during rapid eye movement sleep?

Authors:  C M Shapiro; J R Catterall; I Montgomery; G M Raab; N J Douglas
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-03

Review 5.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Sleep abnormalities and treatment in emphysema.

Authors:  Samuel Krachman; Omar A Minai; Steven M Scharf
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Arterial oxygenation during sleep in patients with right-to-left cardiac or intrapulmonary shunts.

Authors:  J R Catterall; N J Douglas; P M Calverley; C M Shapiro; D C Flenley
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

8.  Endothelin-1 levels in interstitial lung disease patients during sleep.

Authors:  Georgia Trakada; Eugenia Nikolaou; Athanasia Pouli; Maria Tsiamita; Kostas Spiropoulos
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

9.  Effects of a mandibular protruding device on the sleep of patients with obstructive sleep apnea and snoring problems: a 2-year follow-up.

Authors:  Anette M C Fransson; Ake Tegelberg; Lena Leissner; Bengt Wenneberg; Göran Isacsson
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

10.  Familial glaucoma with sleep apnoea: a new syndrome?

Authors:  J T Walsh; J Montplaisir
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.